Phosphodiesterase (PDE)-4 Inhibitors and COPD Correlation with Cancer
John Organtzis, Sofia Lampaki, Paul Zarogoulidis, Haidong Huang, Qiang Li, Antonis Papaiwannou, Konstantinos Syrigos, Κonstantinos Porpodis, Theodora Tsiouda, Wolfgang Hohenforst‐Schmidt, Georgia Trakada, Robert F. H. Walter, Dimitra Makrantonaki, Georgia Pitsiou, Ioannis P. Kioumis, Paul Zarogoulidis · Journal of Cancer · 2014
Not cached yet. This record was fetched live for this request and is stored after the lookup. Reopening the page should serve the cached copy.
Journal of Cancer · Ivyspring International Publisher · article · 2014
Abstract
A new drug for chronic obstructive pulmonary disease has been recently added as a treatment for certain patients. However, new evidences indicate that there might be a connection with lung cancer. It is known that smoking is a major factor that induces chronic pulmonary disease and smoking is associated with lung cancer. The level of connection between phosphodiesterase (PDE)-4 inhibitors and lung cancer will be discussed based on current studies. A comment will be made whether lung cancer is induced to patients receiving phosphodiesterase (PDE)-4 inhibitors from the drug or former smoking habit.
Open the resolved locator · 10.7150/jca.9730
Metadata licence: OpenAlex metadata (CC0)